نتایج جستجو برای: lyp

تعداد نتایج: 229  

Journal: :Journal of immunology 2005
Philippe Poussier Terri Ning Trista Murphy Dominika Dabrowski Sheela Ramanathan

One of the BB rat diabetes (diabetes mellitus (DM)) susceptibility genes is an Ian5 mutation resulting in premature apoptosis of naive T cells. Impaired differentiation of regulatory T cells has been suggested as one possible mechanism through which this mutation contributes to antipancreatic autoimmunity. Using Ian5 congenic inbred rats (wild-type (non-lyp BB) and mutated (BB)), we assessed th...

Journal: :Blood 1996
J F DeCoteau J R Butmarc M C Kinney M E Kadin

Primary cutaneous CD30+ lymphoproliferative disorders (LPDs), including lymphomatoid papulosis (LyP), anaplastic and nonanaplastic CD30+ large-cell lymphoma, and borderline cases, comprise a clinical and histologic spectrum. Primary cutaneous and primary nodal CD30+ anaplastic large-cell lymphomas (ALCLs) are distinct clinical entities that have identical morphologic features but differ in age ...

Journal: :Chemphyschem : a European journal of chemical physics and physical chemistry 2005
Ralf Ludwig

Density functional calculations (B3 LYP/6-31+G*) on molecular clusters and a quantum cluster equilibrium (QCE) model were used to calculate thermodynamic and structural properties of four isotopically labeled methanol species. The method allowed the reproduction of the characteristic differences in boiling points and heats of vaporization. Structural changes were also detected and related to re...

1997
Nam-Su Lee Sang-Woo Cha Su-Jin Hong Won-Yong Shin Gyu-Taeg Lee Jin-Woo Jeon Jong-Ho Won Seung-Ho Baick Dae-Sik Hong Hee-Sook Park

Lymphomatoid papulosis (LyP) is a chronic self-healing skin eruption that is clinically benign but histologically mimics a malignant lymphoma. However, lymphomatoid papulosis with anaplastic large cell lymphoma responds poorly to medical treatments, including chemotherapies. We experienced a 60-year-old male patient with lymphomatoid papulosis occurred simultaneously with relapsed Ki-1-positive...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2010
Ji-Ho Park Geoffrey von Maltzahn Mary Jue Xu Valentina Fogal Venkata Ramana Kotamraju Erkki Ruoslahti Sangeeta N Bhatia Michael J Sailor

A significant barrier to the clinical translation of systemically administered therapeutic nanoparticles is their tendency to be removed from circulation by the mononuclear phagocyte system. The addition of a targeting ligand that selectively interacts with cancer cells can improve the therapeutic efficacy of nanomaterials, although these systems have met with only limited success. Here, we pre...

Journal: :Journal of immunology 2001
J K Moore R I Scheinman D Bellgrau

The cyclin-dependent kinase inhibitor p27(kip) regulates the cell cycle at the G(1)-S phase restriction point. S phase entry and cell cycle commitment in peripheral T cells requires p27(kip) degradation, normally initiated by the receipt of costimulatory signals such as those provided by B7.1 or IL-2. We have previously reported that T cells from BioBreeding (BB)-diabetes-prone (DP) rats exhibi...

Journal: :Chembiochem : a European journal of chemical biology 2013
Rhushikesh A Kulkarni Nadeem A Vellore Matthew R Bliss Stephanie M Stanford Matthew D Falk Nunzio Bottini Riccardo Baron Amy M Barrios

Assay design is an important variable that influences the outcome of an inhibitor screen. Here, we have investigated the hypothesis that protein tyrosine phosphatase inhibitors with improved biological activity could be identified from a screen by using a biologically relevant peptide substrate, rather than traditional phosphotyrosine mimetic substrates. A 2000-member library of drugs and drug-...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید